Northwest Biotherapeutics (NWBO) Gross Margin (2010 - 2013)

Northwest Biotherapeutics' Gross Margin history runs 4 years deep, the most recent figure standing at 100.0% for Q3 2013.

• On a quarterly basis, Gross Margin changed N/A year-over-year to 100.0% in Q3 2013; TTM through Mar 2014 was 100.0%, a 0.0% change from a year earlier, with the FY2013 full-year figure at 100.0%, changed N/A from the prior year.
• Gross Margin held at 100.0% in Q3 2013 per NWBO's latest filing, from 100.0% in the prior quarter.
• Across five years, Gross Margin topped out at 100.0% in Q3 2010 and bottomed at 100.0% in Q3 2010.
• The 4-year median for Gross Margin is 100.0% (2010), against an average of 100.0%.
• Biggest YoY gain for Gross Margin was 0 bps in 2011; the steepest drop was 0 bps in 2011.
• Year by year, Gross Margin stood at 100.0% in 2010, then changed by 0 bps to 100.0% in 2011, then changed by 0 bps to 100.0% in 2012, then changed by 0 bps to 100.0% in 2013.
• Per Business Quant, the three latest NWBO Gross Margin figures stand at 100.0% (Q3 2013), 100.0% (Q2 2013), and 100.0% (Q1 2013).